On Friday, Compass Therapeutics Inc (NASDAQ: CMPX) was 7.86% up from the session before settling in for the closing price of $2.8. A 52-week range for CMPX has been $1.18 – $4.08.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -104.70% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at -53.24%. With a float of $109.99 million, this company’s outstanding shares have now reached $138.28 million.
Compass Therapeutics Inc (CMPX) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Compass Therapeutics Inc stocks. The insider ownership of Compass Therapeutics Inc is 35.91%, while institutional ownership is 43.14%. The most recent insider transaction that took place on May 27 ’25, was worth 21,100. In this transaction CHIEF EXECUTIVE OFFICER of this company bought 10,000 shares at a rate of $2.11, taking the stock ownership to the 6,480,825 shares. Before that another transaction happened on Apr 09 ’25, when Company’s Director sold 3,571,428 for $1.59, making the entire transaction worth $5,678,571. This insider now owns 0 shares in total.
Compass Therapeutics Inc (CMPX) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.08 earnings per share (EPS) during the time that was better than consensus figure (set at -0.11) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -53.24% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -9.23% during the next five years compared to -104.70% drop over the previous five years of trading.
Compass Therapeutics Inc (NASDAQ: CMPX) Trading Performance Indicators
You can see what Compass Therapeutics Inc (CMPX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 7.66.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.45, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.57 in one year’s time.
Technical Analysis of Compass Therapeutics Inc (CMPX)
Let’s dig in a bit further. During the last 5-days, its volume was 1.18 million. That was inferior than the volume of 1.42 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 25.51%.
During the past 100 days, Compass Therapeutics Inc’s (CMPX) raw stochastic average was set at 78.97%, which indicates a significant increase from 44.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.25 in the past 14 days, which was higher than the 0.19 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.83, while its 200-day Moving Average is $2.31. However, in the short run, Compass Therapeutics Inc’s stock first resistance to watch stands at $3.12. Second resistance stands at $3.21. The third major resistance level sits at $3.38. If the price goes on to break the first support level at $2.86, it is likely to go to the next support level at $2.69. The third support level lies at $2.60 if the price breaches the second support level.
Compass Therapeutics Inc (NASDAQ: CMPX) Key Stats
There are 138,283K outstanding shares of the company, which has a market capitalization of 518.14 million. As of now, sales total 850 K while income totals -49,380 K. Its latest quarter income was 0 K while its last quarter net income were -19,880 K.
